BOSTON, MA--(Marketwire - March 04, 2009) - PHT Corporation continues to move the bio-pharmaceutical industry forward at key conferences. PHT is the leading provider of ePRO (electronic patient reported outcome) solutions used in more than 380 clinical trials worldwide.
Cambridge Health Tech Institute’s Inaugural Electronic Data in Clinical Trials Conference, March 11-12, Miami
On March 11, PHT Vice President of Marketing and Product Management Sheila Rocchio, MBA, will present, “The Integration of ePRO with other eClinical Systems.” Ms. Rocchio will review what sponsors and sites need to know about ePRO including the multiple types of ePRO systems, the history and rationale for using ePRO, and the integration of ePRO with other eClinical systems. Additionally, PHT will demonstrate its groundbreaking ePRO solutions at its conference booth.
DIA 21st Annual EuroMeeting, March 23-25, Berlin
PHT will demonstrate and preview its advanced ePRO products at Booth #1595.
On March 24, Valdo Arnera, MD and General Manager of PHT Europe will chair a session, “Integrating Different eClinical Data Streams: Needs and Benefits.” With the increasing use of electronic means of collecting data during clinical trials, it is becoming tempting to integrate all these data streams as soon as possible. This session explores present solutions and looks at the future.
Also on March 24, Dr. Steve Raymond, PHT’s CSO and Quality Officer, will chair a session, “Are the Benefits of eClinical Methods in Step with Regulations and Recent EMEA Guidance?” There are many advantages in efficiency, cost and data quality when eSource data are captured directly from electronic health records and eRecords completed directly by clinical study subjects. This discussion will focus on the promise of eSource and the challenges to its optimum adoption.
About PHT Corporation
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 390 clinical trials by 110 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad™ Tablet deliver the voice of the patient, in 80 languages, from homes and sites in 60 countries around the world. By capturing high-quality and time-stamped assessments with minimal respondent burden, trial sponsors are able to run smaller and more conclusive clinical research programs resulting in significant R&D cost savings. Real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry’s premier study archive. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least 11 NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com
PHT, LogPad, eSense, StudyWorks, SafetyPRO and SitePad are among the registered trademarks and trademarks of PHT Corporation.
Contact:
Brenda Nashawaty
Email Contact
617-688-3253
